For its fourth fiscal quarter (ending December 31), EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) has reported a 94% increase in E.P.S. from $-0.33 a year ago to $-0.64 in the current quarter. E.P.S. were $-2.32 for […]
Culp Inc. (NYSE: CULP) has reported E.P.S. of $-0.33 for its third fiscal quarter (ending January 31) versus $-0.26 for the same period a year ago — an increase of 27%. For the latest four […]
For its fourth fiscal quarter (ending January 31), Veeva Systems Inc (NYSE: VEEV) has reported a 30% increase in E.P.S. from $0.92 a year ago to $1.20 in the current quarter. E.P.S. were $4.41 for […]
Endeavour Silver Corp (NYSE: EXK) stock enjoyed a major increase of 11.4% on 3/5/25. The shares closed at $4.02. NORMAL trading volume accompanied the advance. The stock has performed in line with the market over […]
Daktronics Inc (NASDAQ: DAKT) stock suffered a major decline of -14.9% on 3/5/25. The shares closed at $12.19. Moreover, this decline was accompanied by exceptionally high trading volume at 462% of normal. The stock has […]
On 3/5/25, ChromaDex Corp (NASDAQ: CDXC) stock enjoyed a major increase of 52.7%, closing at $8.55. Moreover, trading volume in this advance was exceptionally high at 2390% of normal. The stock has risen 57.2% during […]
Thor Industries Inc. (NYSE: THO) has reported a loss for its second fiscal quarter (ending January 31) of $-0.01 versus $0.14 for the same period a year ago — a decline of -107%. For the […]
For its fourth fiscal quarter (ending January 31), Marvell Technology Inc (NASDAQ: MRVL) has reported a -151% decline in E.P.S. from $-0.45 a year ago to $0.23 in the current quarter. For the latest four […]
On 3/5/25, Celanese Corp (NYSE: CE) stock enjoyed a major increase of 12.7%, closing at $54.33. Moreover, this advance was accompanied by unusually high trading volume at 187% of normal. Relative to the market the […]
On 3/5/25, comScore Inc (NASDAQ: SCOR) stock enjoyed a major increase of 21.5%, closing at $6.94. Moreover, trading volume in this advance was exceptionally high at 396% of normal. Relative to the market the stock […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research